Tag Archives: EMA

Every new diabetes medication must prove it is both safe and effective before reaching patients. Traditionally, that process depends on large clinical trials that require thousands of volunteers, years of follow-up, and significant financial investment. However, what if researchers could reduce the number of participants while still producing reliable scientific …

Read More »